Home > Boards > US OTC > Cannabis >

Greater Cannabis Company Inc. (GCAN)

GCAN RSS Feed
Add GCAN Price Alert      Hide Sticky   Hide Intro
Moderator: Sheepdog, Diogenes of Sinope, Taurus69, ED25, downandoutthanksd, Babubd
Search This Board: 
Last Post: 3/7/2021 9:26:33 PM - Followers: 249 - Board type: Free - Posts Today: 0

GCAN Corporate Presentation

https://www.gcanrx.com/assets/corporate-presentation.pdf





https://www.healtheuropa.eu/symtomax-cbd-oral-tab-innovative-delivery-for-cannabinoids/96373/









https://www.healtheuropa.eu/symtomax-the-medical-cannabis-company-leading-the-field/94127/

October 17, 2019

Symtomax are at the forefront to offer cheaper production, providing products at the certification grade Europe requires. With current demand outstripping supply in the European Union, it’s easy to see why Symtomax are confident about how they have positioned themselves. Symtomax’s vision and strategic direction is evident in the recently announced partnership. In May of this year Symtomax and Greater Cannabis Company a publicly traded biopharmaceutical, based out of Baltimore, with a focus on the development and commercialisation of cannabinoid delivery systems, signed a joint agreement giving rights to use their tested patented delivery products & distribution throughout Europe, Middle East and Africa.

With concern growing over vaping and the numerous incidents now being reported, Symtomax’s new oral patch, provides a safe alternative delivery platform that can be utilised to deliver cannabinoids directly into the body without the harmful side effects of smoking or vaping, and with quicker onset and greater bioavailability than ingestibles.

This new Innovative delivery system using a bio-adhesive, adjustable dose, and fully dissolvable, non-irritant patch, provides for a needle free, intra-oral systemic drug delivery.

Paul Segal, Chairman said: “Our focus has always been on providing safe, accessible, alternative medicines, with patients and consumers demanding safer routes of administration, while achieving proper potency and higher bioavailability, we believe we can now meet this need as well as the expectations.”

Symtomax have established sales and distribution arrangements to supply their cannabinoid-containing products through major pharmaceutical distribution channels throughout Portugal and the European Union (EU). The conveyance technology is designed to accelerate and enhance the delivery and bioavailability of medicines and cannabis actives when compared to traditional methods of enteral administration




MEET THE GCANRX DREAM TEAM:
     
            Aitain Zacharin, CEO                   Mark Randon, Esquire / General Counsel       David Tavor, Board of Directors                       Dr. Hock S. Tan, PHD        

“By improving the bioavailability of cannabinoids molecules we can deliver lower doses of actives while achieving greater therapeutic efficacy.”
- Aitan Zacharin, CEO of GCANRx
http://www.gcanrx.com

VIEW THE GCAN CEO INTERVIEW ON CHEDDAR TV
https://cheddar.com/media/gcanrx-offers-an-adjustable-and-dissolvable-cannabis-patch

View the GCAN CEO INTERVIEW ON CEO MONEY - Episode 28
https://www.youtube.com/watch?v=ZwI48a46KjI&feature=youtu.be


 SHARE STRUCTURE
Market Cap 
415,838
05/15/2020
 
Authorized Shares
500,000,000
05/18/2020
 
Outstanding Shares
75,882,842
05/18/2020
 
Restricted
Not Available

Unrestricted
Not Available
 
Held at DTC
Not Available
 
Float
47,056,987
04/19/2020
 
https://www.otcmarkets.com/stock/GCAN/security

Transfer Agent contact information:

Luke Chakmakdjia
Client Services Representative
Pacific Stock Transfer
702-361-3033 Ext 111 Phone
800-785-7782 Toll Free Phone
702-433-1979 Fax

 

 
http://greatercannabiscompany.com

The Greater Cannabis Company, Inc.

Contact us

THE GREATER CANNABIS COMPANY, INC.
Corporate Headquarters
15 Walker Ave.
Suite 101
Pikesville / Baltimore, MD 21208

info@greatercannabiscompany.com

The Greater Cannabis Company is a holding corp whose investment strategy is centered around the cannabis sector through direct investments, acquisitions, joint ventures and e-commerce.

Patent information:
Here is patent information:

https://patents.google.com/patent/WO2010135053A2/en?oq=Dual+and+single+layer+dosage
Inventor:
Hock Seng Tan
Siew Lian Chung

Original Assignee
Bionex Pharmaceuticals Llc
Priority date
2009-05-21
http://bionexpharma.com/Management.aspx

GCAN NEWS by Date:

Q10 Report - SEC Filing May 18, 2020

https://www.sec.gov/Archives/edgar/data/1695473/000149315220009301/form10-q.htm

Anual Report - April 15, 2020
https://www.sec.gov/Archives/edgar/data/1695473/000149315220006408/form10-k.htm

February 12. 2020 - S1 EFFECTIVE
https://www.sec.gov/Archives/edgar/data/1695473/999999999520000333/xslEFFECTX01/primary_doc.xml

February 10. 2019 - S1/A Filed with SEC
https://www.sec.gov/Archives/edgar/data/1695473/000149315220001855/forms-1a.htm

February 3, 2020 - 8K filed with SEC
https://www.sec.gov/Archives/edgar/data/1695473/000149315220001485/form8-k.htm

January 30, 2020- GCAN Receives Purchase order for 125,000 Units of its Oral Tab from Symtomax
http://www.globenewswire.com/news-release/2020/01/30/1977601/0/en/GCAN-Receives-Purchase-Order-for-125-000-Units-of-its-Oral-Cannabis-Patch-from-Symtomax.html

January 19, 2020 - Anual Report Filed with Florida Department of State
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityName&directionType=Initial&searchNameOrder=GREATERCANNABIS%20P170000045370&aggregateId=domp-p17000004537-69a1f1d7-2049-4ebf-bb2d-ecbb1559d26b&searchTerm=greater%20cannabis%20company&listNameOrder=GREATERCANNABIS%20L140000462060

January 16, 2020-  Beneficial Ownership Filings S-1
https://www.sec.gov/Archives/edgar/data/1695473/000149315220000672/forms-1.htm

December 2, 2019 - Benificial Ownership Filing S-1
https://www.sec.gov/Archives/edgar/data/1695473/000149315219018743/0001493152-19-018743-index.htm

November 29- Beneficial Ownership Filings SEC
https://www.sec.gov/Archives/edgar/data/1400065/000149315219018563/xslF345X03/ownership.xml

November 18, 2019 - SEC 3rd Quarter Filings FORM 10-Q
https://www.sec.gov/Archives/edgar/data/1695473/000149315219017819/form10-q.htm

November 13, 2019 -FORM 12b-25  SEC Notification of Late Filing
https://www.sec.gov/Archives/edgar/data/1695473/000149315219016965/formnt10-q.htm

November 12, 2019 -Greater Cannabis Company Advances CBD Study With Researchers From Israel Cannabis Research Center
https://www.globenewswire.com/news-release/2019/11/12/1945577/0/en/Greater-Cannabis-Company-Advances-CBD-Study-With-Researchers-From-Israel-Cannabis-Research-Center.html

October 23, 2019- Edgar Search 3Q 8K -SEC File
https://www.sec.gov/Archives/edgar/data/1695473/000149315219015857/form8-k.htm

October 21, 2019-Former Portugal State Secretary of Health Joins Greater Cannabis Company’s European Partner, Symtomax
http://www.globenewswire.com/news-release/2019/10/21/1932612/0/en/Former-Portugal-State-Secretary-of-Health-Joins-Greater-Cannabis-Company-s-European-Partner-Symtomax.html?ev=1

October 15, 2019 - The Greater Cannabis Company Expands CBD Delivery Portfolio With Newly Developed Transdermal Patch
https://markets.businessinsider.com/news/stocks/the-greater-cannabis-company-expands-cbd-delivery-portfolio-with-newly-developed-transdermal-patch-1028599131

September 21, 2019 - GCAN CEO Aitan Zacharin to be interviewed on Yahoo Finance News
CEO will appear on the On The Move show to discuss Company’s technology as a high-tech alternative to vaping devices,
why the GCANRx patch is safer, and what’s in the pipeline for the future.
https://finance.yahoo.com/news/greater-cannabis-ceo-interviewed-today-125624622.html

https://finance.yahoo.com/video/gcanrx-offers-oral-patch-cannabinoid-170756517.html
 

September 19, 2019 - Corporate Update to Shareholders
http://www.globenewswire.com/news-release/2019/09/19/1918060/0/en/The-Greater-Cannabis-Company-Provides-Corporate-Update-to-Shareholders.html?ev=1

August 20, 2019 -Q2 Report SEC 10Q
https://www.sec.gov/Archives/edgar/data/1695473/000149315219012969/form10-q.htm

August 5, 2019 - PRE-14C
https://www.sec.gov/Archives/edgar/data/1695473/000149315219011598/formpre14c.htm

July 23, 2019 - Amended 10k/A
https://www.sec.gov/Archives/edgar/data/1695473/000149315219010967/form10-ka.htm

June 25, 2019 - Letter of Intent with RST, Inc
http://www.globenewswire.com/news-release/2019/06/25/1873932/0/en/Greater-Cannabis-Company-Signs-letter-of-intent-LOI-with-RST-Inc.html?ev=1

http://rstincbeauty.com/

May 20, 2019 - FORM 10-Q Report (Quarterly Financials)
https://www.sec.gov/Archives/edgar/data/1695473/000149315219007846/form10-q.htm

May 7, 2019 - GREATER CANNABIS COMPANY PARTNERS WITH SYMTOMAX®
TO EXPAND ACROSS EUROPE, THE MIDDLE EAST AND AFRICA


http://www.globenewswire.com/news-release/2019/05/07/1818383/0/en/GREATER-CANNABIS-COMPANY-PARTNERS-WITH-SYMTOMAX-TO-EXPAND-ACROSS-EUROPE-THE-MIDDLE-EAST-AND-AFRICA.html?ev=1

https://www.symtomax.com/

May 1, 2019 -CEO to Discuss Initial Stage of the Global Commercialization of His Company’s
Proprietary Cannabinoid Delivery System, which Resemble “LISTERINE’S POCKETPACKS®
http://www.globenewswire.com/news-release/2019/05/01/1813622/0/en/Greater-Cannabis-CEO-to-be-Interviewed-Today-By-Cheddar-Financial-News-Live-From-the-New-York-Stock-Exchange.html?ev=1

April 16, 2019 - GCAN Licenses CBD Patch Technology to
Majory Brazilian Retail Pharmacy Company

http://www.globenewswire.com/news-release/2019/04/16/1804688/0/en/GREATER-CANNABIS-COMPANY-LICENSES-CBD-PATCH-TECHNOLOGY-TO-MAJOR-BRAZILIAN-RETAIL-PHARMACY-COMPANY.html?ev=1

April 15, 2019 - SEC Update 10K
https://www.sec.gov/Archives/edgar/data/1695473/000149315219005257/form10-k.htm

April 11, 2019 - GCAN Partners with Allume Cosmeticos
to Develope New Cosmetics Line


http://www.allume.com.br/web/

https://www.otcmarkets.com/stock/GCAN/news/Greater-Cannabis-Company-Partners-with-Allume-Cosmeticos-To-Develop-New-Cosmetics-Line?id=224537

April 8, 2019 -GCAN Announces Expansion into CBD Cosmetic and Beauty Market
http://www.globenewswire.com/news-release/2019/04/09/1799720/0/en/Greater-Cannabis-Company-Announces-Expansion-Into-CBD-Cosmetics-And-Beauty-Market.html?ev=1

April 1, 2019 -Clinical Trials Begin
http://www.globenewswire.com/news-release/2019/04/01/1790833/0/en/GREATER-CANNABIS-TO-BEGIN-CLINICAL-STUDY-OF-CBD-ABSORPTION-THROUGH-ITS-MULTIFUNCTIONAL-MULTILAYER-INTRA-ORAL-DRUG-DELIVERY-TECHNOLOGY.html?ev=1

March 8, 2019 - 9,000,000 Prefered Shares AMENDMENT
http://search.sunbiz.org/Inquiry/CorporationSearch/ConvertTiffToPDF?storagePath=COR%5C2019%5C0313%5C24613995.Tif&documentNumber=P17000004537

February 27, 2019 - UPLISTING TO OTCQB COMPLETE
http://globenewswire.com/news-release/2019/02/27/1743521/0/en/The-Greater-Cannabis-Company-Announces-Uplisting-To-New-Market-Tier.html?ev=1

February 15, 2019 - SEC - 8K - Current Report
https://www.sec.gov/Archives/edgar/data/1695473/000149315219002166/form8-k.htm
Item 1.01 Entry into a Material Definitive Agreement.
Eagle Note

February 14, 2019 - FORM 8-A SEC Filed
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
https://www.sec.gov/Archives/edgar/data/1695473/000149315219002039/form8a-12g.htm

February 13, 2019 - OTCQB Certification Filed
https://backend.otcmarkets.com/otcapi/company/financial-report/211786/content

February 5, 2019 - OTCQB Certification filed
https://backend.otcmarkets.com/otcapi/company/financial-report/211467/content

January 28, 2019 - Annual Report (Florida) Filed
http://search.sunbiz.org/Inquiry/CorporationSearch/GetDocument?aggregateId=domp-p17000004537-69a1f1d7-2049-4ebf-bb2d-ecbb1559d26b&transactionId=p17000004537-2c800c85-d1af-438b-8bc1-d1c585105683&formatType=PDF

January 27, 2019 - Israel Gives Green Light to Medical Cannabis Exports
https://www.jpost.com/Israel-News/Israel-gives-green-light-to-medical-cannabis-exports-578815

January 25, 2019- OTCQB Certification
https://backend.otcmarkets.com/otcapi/company/financial-report/210982/content

January 23, 2019 - OTC MARKETS Registering to UPLIST OTCQB
https://backend.otcmarkets.com/otcapi/company/financial-report/210930/content

January 3, 2019 - FORM 3 Filed OTCMARKETS`
Benificial Ownership Registration

https://www.otcmarkets.com/filing/html?id=13165789&guid=GTRtUWzJqe9Gcth

January 7,2019 - World Wide Distribition Deal with Ican
https://www.israel-cannabis.com/

http://globenewswire.com/news-release/2019/01/07/1681268/0/en/The-Greater-Cannabis-Company-Announces-Distribution-Agreement-With-Leading-Global-Cannabis-Company-iCAN-Israel-Cannabis-Ltd.html?ev=1

November 19, 2018 - FORM 10 Q
https://www.sec.gov/Archives/edgar/data/1695473/000149315218016446/form10-q.htm

November 15, 2018 - 8K/8 Amendment No.1
https://www.sec.gov/Archives/edgar/data/1695473/000149315218016259/form8-ka.htm


 

   

November 2, 2018 - News Release
Innovative Cannabis Delivery Technologies on the Rise:
The Greater Cannabis Company, Inc. (OTC: GCAN), Aphria, Tilray, Aurora and Canopy Growth
https://globenewswire.com/news-release/2018/11/02/1641958/0/en/Innovative-Cannabis-Delivery-Technologies-on-the-Rise-The-Greater-Cannabis-Company-Inc-OTC-GCAN-Aphria-Tilray-Aurora-and-Canopy-Growth.html

October 31, 2018 - News Release
The Greater Cannabis Company to Update Shareholders on Corporate Strategy and
Developments of Eluting Patch Platform (EPP) for Cannabinoid Use
https://globenewswire.com/news-release/2018/10/31/1640546/0/en/The-Greater-Cannabis-Company-to-Update-Shareholders-on-Corporate-Strategy-and-Developments-of-Eluting-Patch-Platform-EPP-for-Cannabinoid-Use.html

October 11, 2018 - The Greater Cannabis Company Files Additional Patent
to Further Protect Proprietary Cannabinoid Delivery System

http://www.globenewswire.com/news-release/2018/10/11/1620215/0/en/The-Greater-Cannabis-Company-Files-Additional-Patent-to-Further-Protect-Proprietary-Cannabinoid-Delivery-System.html

October 8, 2018 - New Corporate Website was launched
http://gcanrx.com/

October 4, 2018 - The Company Appoints Dr. Hock Tan as Chairman of Scientific Advisory Board
https://globenewswire.com/news-release/2018/10/04/1601401/0/en/The-Greater-Cannabis-Company-Appoints-Dr-Hock-Tan-as-Chairman-of-Scientific-Advisory-Board.html

September 26, 2018 - 8K filed with Sec
https://www.sec.gov/Archives/edgar/data/1695473/000149315218013804/form8-k.htm

September 24, 2018 - News Release

The Greater Cannabis Company Announces Appointment of David Tavor to its Board of Directors
https://www.otcmarkets.com/stock/GCAN/news/story?e&id=1178022

The Greater Cannabis Company Inc.

https://www.otcmarkets.com/stock/GCAN/security

 

PharMedica is a privately held company founded in 2008, specializing in the Biotech and Medical Device industries.The company developed an “Eluting Bandage Platform” - a multifunctional, multilayer, intra-oral drug delivery platform.This mucoadhesive film is applied on the internal mouthtissue. Firmly attached yet totally non-irritant, it disintegrates and dissolves as the treatment progresses.The Eluting Bandage Platform is aimed at two major markets: Oral-Care, and Trans-membrane Drug Delivery.

THIS EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is made and entered into as of June 21, 2018 (the “Effective Date”), by and between Pharmedica Ltd. an Israeli company (“Pharmedica”), and Green C Corporation a company incorporated under the laws of Canada with its principal place of business at 1 Whitehorse Road, Unit 16, Toronto, Ontario M3J 3G8 (“Licensee”). Pharmedica and Licensee each may be referred to herein individually as a “Party,” or collectively as the “Parties”.

Green C Corporation: 1 Whitehorse Road, Unit 16, Toronto, Ontario M3J 3G8

Tel: 416-661-0728; Attn: Elisha Kalfa; E-mail: elisha@focusglobalsupply.com

Pharmedica: 9 Andre Saharov, Matam, Building #25, Haifa 508409, Tel: +(972) 04 8342155; Fax: +(972) 04 8341233 Attn: Dr. Yoram Rubin, CEO E-mail yrubin@pharmedica.co.il

with a copy (which shall not constitute notice) to: Tulchinsky Stern Marciano Cohen Levitski & Co., 4 Berkowitz Street, Museum Tower, 12th Floor, Tel-Aviv 6423806, Fax: +972-3-607-5050, Attn: Adv. Alon Tabak Aviram; Email: alont@tslaw.co.il.

 
 

Annex B – Patent(s)/Patent Application(s)

1. WO 2012/104834 A1

New oral dissolving films for insulin administration, for treating diabetes.

filed on December 2011. National Phase at Israel and the USA.

2. WO 2010/135053 A2

Dual and single layer dosage forms.

Issued USA patent on April 28, 2015.

3. PCT/IL 2017/050845

Adhesive Oral dissolved Films in Managing Oral Care.

PCT on 31 July 2017.

1

Annex C – Diligence Milestones

Licensee is required to meet the following development/regulatory/commercialization milestones in order to retain the license:

  ? Successful completion of the development of product samples by the end of year 1, provided there are no delays which are under the control of Licensee, its Affiliates or Subcontractors and any such delays not under their control will be deemed to extend such period, commensurate with such delay.
     
  ? Successful completion of product scale-up and receipt of regulatory marketing approval by the end of year 3, provided there are no delays which are under the control of Licensee, its Affiliates or Subcontractors and any such delays not under their control will be deemed to extend such period, commensurate with such delay.
     
  ? First commercial sale by the end of year 3 in any of the following territories: US, Canada, Japan, western Europe, provided there are no delays which are under the control of Licensee, its Affiliates or Subcontractors and any such delays not under their control will be deemed to extend such period, commensurate with such delay.
     
  ? $50,000 in annual sales each year from years 5-9
     
  ? $100,000 in annual sales each year from year 10 onwards
     
     
     
     
     
     
     
     
     

 

 

________________________________________________________________________________________________________

August 20, 2018 - 10Q Edgar Search
https://www.sec.gov/Archives/edgar/data/1695473/000149315218012327/form10-q.htm

JULY 31, 2018 _ NEW OWNERSHIP LISTED ON 8k THIS COULD BE HUGE

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001695473&owner=include&count=40

As a condition to the closing of the Exchange Transaction, effective July 31, 2018, the Board of Directors of the Company (the “Board”) appointed Aitan Zacharin as Director and Chief Executive Officer of the Company and Mark Radom as chief legal officer of the Company.

Mark Radom previously held the positions President, Chief Executive Officer, Chief Financial Officer, Treasurer and Secretary of Graphite Corp. Although there was no arrangement or understanding between Mark Radom and any other person(s) pursuant to which he was selected as chief legal officer of the Company, the Selling Shareholders decided on their own initiative to offer Mr. Radom the position of chief legal officer. Mark Radom has no family relationships with any director or executive officer of the Company, or persons nominated or chosen by the Company to become directors or executive officers. Furthermore, the Company is not aware of any transaction involving Mark Radom requiring disclosure under Item 404(a) of Regulation S-K, except for the Exchange Transaction.

The Board believes that Mr. Radom’s extensive experience in business development, management of complex projects and legal services in connection therewith will be invaluable in achieving the Company’s goals.

Professional History of Aitan Zacharin

Mr. Zacharin is an experienced executive with a broad knowledge in building and managing technology and consumer products businesses. In 2012, he co-founded Fuse Science, an innovative biotechnology company headquartered in Miami, Florida and Oxnard, California. Mr. Zacharin was responsible for the development and growth of the business from a seed stage R&D company to a publicly traded CPG and biotech business with multiple subsidiaries. During his tenure he was tasked with expanding the biotechnology IP portfolio, spearheading multiple in vitro studies, and growing the consumer products business. In scaling the company, Mr. Zacharin identified and hired executive talent to lead the commercialization strategy including the past President of SC Johnson Company and previous CEO of Champs and Footlocker Sports. He successfully led the company to raise over $10M in three over-subscribed rounds, as well as negotiated contracts with 26 world renowned athlete and celebrity brand ambassadors, which included top ranked pro golfer Tiger Woods. Under Mr. Zacharin’s leadership the company developed and commercialized multi-category consumer products through a retail footprint of 15,000 doors. Since his exit from Fuse Science, he has been advising and investing in mid to late stage technology startups, and assisting them with capitalization, business strategy and development, and accelerating growth. Mr. Zacharin holds dual degrees from the University of South Florida in Tampa Bay. He resides in Baltimore, Maryland, and maintains various board appointments both professionally and philanthropically.

Professional History of Mark Radom

From August 2015 to July 2018, Mr. Radom served as chief executive officer of Graphite Corp. From February 2010 through July 2015, Mr. Radom served as the chief carbon officer and general counsel of Blue Sphere Corporation. From 2009 through 2010, Mr. Radom was managing director of Carbon MPV Limited, a Cyprus company focused on developing renewable energy and carbon credit projects. From 2007 to 2009, Mr. Radom was general counsel and chief operating officer of Carbon Markets Global Limited, a London-based carbon credit and renewable energy project developer. Mr. Radom has extensive experience in business development in the renewable energy and carbon credit sectors. He has sourced over U.S. $100,000,000 in renewable energy, industrial gas and carbon credit projects and managed many complex aspects of their implementation. He was legal counsel for a number of carbon and ecological project developers and was responsible for structuring joint ventures and advising on developing projects through the CDM/JI registration cycle and emission reduction purchase agreements under the auspices of the Kyoto Protocol. Prior to this, he worked on Wall Street and in the City of London as a US securities and capital markets lawyer where he represented sovereigns, global investment banks and fortune 500 companies across a broad range of capital raising and corporate transactions. He is a graduate of Duke University and Brooklyn Law School. Mr. Radom is admitted to practice law in New York and New Jersey and speaks fluent Russ

     

(d)       Appointment of Directors

As a condition to the closing of the Exchange Transaction, effective July 31, 2018, the Board appointed Aitan Zacharin as a director of the Company. Mr. Zacharin does not have any family relationships with any other executive officers or directors of the Company, or persons nominated or chosen by the Company to become directors or executive officers. There is no arrangement or understanding pursuant to which Mr. Zacharin was appointed as a member of the Board. Furthermore, the Company is not aware of any transaction requiring disclosure under Item 404(a) of Regulation S-K, except for the Exchange Transaction. It is contemplated that Mr. Zacharin may serve on certain committees of the Board, but no such committee appointments have been made at this time.

Here's something more:

https://www.sec.gov/Archives/edgar/data/1695473/000149315218010899/form8-k.htm

This document shows it dated at the bottom left.

https://www.sec.gov/Archives/edgar/data/1695473/000149315218010899/ex2-1.htm

July 10, 2018 - SEC Edgar Search GCAN EFFECTIVE

https://www.sec.gov/Archives/edgar/data/1695473/999999999518001730/9999999995-18-001730-index.htm
 

GCAN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GCAN News: Quarterly Report (10-q) 11/19/2020 10:35:41 AM
GCAN News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 11/16/2020 06:31:25 AM
PostSubject
#47004  Sticky Note They have not harvested a single gram. Sheepdog 03/01/21 04:46:19 PM
#46719  Sticky Note Member when we had 25 milly O/S HEAR!? downandoutthanksd 02/12/21 12:12:42 AM
#36614  Sticky Note Current amount of shares already sold by GCAN Sheepdog 04/25/20 04:16:20 PM
#47199   Our Oral Tabs are better because they have Luckyus 03/07/21 09:26:33 PM
#47198   What you guys think about this? Luckyus 03/07/21 09:26:07 PM
#47197   Now that I agree with! More BS Sprycel 03/07/21 09:06:49 PM
#47196   Please provide a link showing buccal absorption is Sheepdog 03/07/21 08:27:06 PM
#47195   I wouldn't know about the bottom of the Sheepdog 03/07/21 08:23:14 PM
#47194   YEP, also good to know what your taking Sprycel 03/07/21 07:32:12 PM
#47193   Yep....so any claim that the "lab reports" provide Sheepdog 03/07/21 07:23:31 PM
#47192   Always good to know that there is NO Sprycel 03/07/21 07:19:09 PM
#47191   Our Oral Tabs are better because they have Luckyus 03/07/21 07:07:58 PM
#47190   Here's the vaunted lab report. Says nothing Sheepdog 03/07/21 06:39:16 PM
#47189   A better question is what did he do Sheepdog 03/07/21 06:28:32 PM
#47188   How can Aitan be selling shares if there Sprycel 03/07/21 05:22:46 PM
#47187   Good question! The ? Should be directed to Aitan. Luckyus 03/07/21 05:19:39 PM
#47186  Restored ROFLMAO.........now the bottom of the BS barrel has Sprycel 03/07/21 04:50:08 PM
#47185   The lab reports only said there is no Sheepdog 03/07/21 04:23:05 PM
#47184   This should bbe bbigger than Tsla as speaking!! Luckyus 03/07/21 03:45:08 PM
#47183   Yes No shares have been added since. NO 29YEARINVESTOR 03/07/21 01:19:16 PM
#47179   Are we talking about one kind of debt Sheepdog 03/07/21 12:29:56 PM
#47177   So there is NO PROOF that he has Sprycel 03/07/21 12:26:31 PM
#47176   He has stacks of them ready at any Sheepdog 03/07/21 12:18:38 PM
#47175   If no shares have been added to the Sprycel 03/07/21 12:09:55 PM
#47174   It is indeed a TRADER's dream....It is just Sheepdog 03/07/21 11:57:48 AM
#47173   It is indeed becoming obvious where the distorting Sheepdog 03/07/21 11:55:06 AM
#47172   GCAN is a TRADERS Dream! 29YEARINVESTOR 03/07/21 09:21:20 AM
#47171   LoL! We know corrupt hedge funds there brokers, 29YEARINVESTOR 03/07/21 09:21:20 AM
#47168   Now that remaining debt has been retired, Bullshit. Sheepdog 03/06/21 08:04:01 PM
#47167   YES! GCAN shares are very Valuable. Many have 29YEARINVESTOR 03/06/21 07:40:39 PM
#47166   Oh please 99.99% short win and I believe Luckyus 03/06/21 07:06:03 PM
#47164   The claim that ALL debt has been paid Sheepdog 03/06/21 05:11:14 PM
#47163   Made-up false statements have no credibility and fools 29YEARINVESTOR 03/06/21 04:09:03 PM
#47162   Where does it say Aitan paid off ALL Sheepdog 03/06/21 03:59:19 PM
#47161   Aitain announced it 1-20-21.everyone that does DD instead 29YEARINVESTOR 03/06/21 03:54:38 PM
#47160   Highly dought she got that happy from cbd. makinbacon1 03/06/21 01:38:49 PM
#47159   It is a pleasure seeing a happy grandma! Luckyus 03/06/21 01:13:51 PM
#47158   When did Aitan announce all debt was paid Sheepdog 03/06/21 12:28:14 PM
#47157   How many shares have been added to the Sprycel 03/06/21 12:21:14 PM
#47156   Wow...that sure looks like more than 200M shares.... Sheepdog 03/06/21 12:07:59 PM
#47155   OH NO!! WONDER WHERE ALL THESE SHARES Sprycel 03/06/21 09:32:41 AM
#47154   Where does "going back 180 days" come from? Sheepdog 03/05/21 07:25:53 PM
#47153   Aitan so full of crap again. It Sheepdog 03/05/21 06:14:37 PM
#47152   But it is ALL PAID OFF!!! DEBT Sprycel 03/05/21 03:35:52 PM
#47151   What was the reason for the debt? Couldn't makinbacon1 03/05/21 03:32:29 PM
#47150   A very smart business man to get ALL Sprycel 03/05/21 03:27:18 PM
#47149   BULLSHIT! All the prices going back 180 Sprycel 03/05/21 03:25:25 PM
#47148   400 million shares, yep he sure did pay makinbacon1 03/05/21 03:23:07 PM
#47147   Filing requirements? When did they file? Sheepdog 03/05/21 02:56:18 PM
#47146   BULLSHIT!!! It was posted on this board Sprycel 03/05/21 02:53:24 PM
#47145   Now that is proof...it was posted on this Sheepdog 03/05/21 02:35:20 PM
#47144   Pretty sure I know what level. I just midas716 03/05/21 01:37:10 PM
#47143   BTW anyone else using Fidelity Active Trader Pro midas716 03/05/21 01:33:17 PM
PostSubject
Consent Preferences